Cash flow InnoCan Pharma Corporation

Equities

INNO

CA45783P5085

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 11:48:54 2026-03-03 am EST			5-day change	1st Jan Change
6.100 ^CAD	-9.63%		-12.86%	-8.96%

Feb. 27	InnoCan Pharma Corporation Receives Third Consecutive FDA CVM Fee Waiver For LPT-CBD Product	CI
Feb. 09	InnoCan Pharma Says Latest LPT-CBD Trial Involving Dogs Published in Peer-Reviewed Journal	MT

bb75ae0f9.6GJu7vR39LrpqBpuNJDOTJySxJYhdG28NSpscejSVyQ.0TUepL0QxM6Yx28ZeNqoBNS_qsF0LDvweBItPYWQHFC8IQOsoEa-jLjLaQ

Published financial data: INNOCAN PHARMA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8K	196K	2.56M	13.66M	29.44M
Total Revenues	8K	196K	2.56M	13.66M	29.44M
Cost of Goods Sold, Total	5K	75K	452K	1.68M	3.25M
Gross Profit	3K	121K	2.11M	11.98M	26.19M
Selling General & Admin Expenses, Total	2.98M	6.2M	6.85M	13.98M	25.88M
R&D Expenses	1.74M	1.4M	1.53M	1.8M	1.55M
Other Operating Expenses, Total	4.73M	7.6M	8.37M	15.78M	27.43M
Operating Income	-4.72M	-7.48M	-6.27M	-3.8M	-1.25M
Interest Expense, Total	-	-13K	-2K	-	-7K
Interest And Investment Income	21K	-	-	-	-
Net Interest Expenses	21K	-13K	-2K	-	-7K
Currency Exchange Gains (Loss)	-	-290K	-415K	4K	-42K
Other Non Operating Income (Expenses)	-5.25M	-2.31M	2.8M	-235K	2.22M
EBT, Excl. Unusual Items	-9.95M	-10.09M	-3.89M	-4.03M	919K
EBT, Incl. Unusual Items	-9.95M	-10.09M	-3.89M	-4.03M	919K
Income Tax Expense	-	-	1K	214K	1.18M
Earnings From Continuing Operations	-9.95M	-10.09M	-3.89M	-4.25M	-262K
Net Income to Company	-9.95M	-10.09M	-3.89M	-4.25M	-262K
Minority Interest	-	44K	125K	-452K	-1.57M
Net Income - (IS)	-9.95M	-10.05M	-3.76M	-4.7M	-1.83M
Net Income to Common Incl Extra Items	-9.95M	-10.05M	-3.76M	-4.7M	-1.83M
Net Income to Common Excl. Extra Items	-9.95M	-10.05M	-3.76M	-4.7M	-1.83M
Per Share Items
Net EPS - Basic	-3.99	-2.91	-0.98	-1.19	-0.43
Basic EPS - Continuing Operations	-3.99	-2.91	-0.98	-1.19	-0.43
Basic Weighted Average Shares Outstanding	2.49M	3.45M	3.83M	3.95M	4.31M
Net EPS - Diluted	-3.99	-2.91	-0.98	-1.19	-0.43
Diluted EPS - Continuing Operations	-3.99	-2.91	-0.98	-1.19	-0.43
Diluted Weighted Average Shares Outstanding	2.49M	3.45M	3.83M	3.95M	4.31M
Normalized Basic EPS	-2.5	-1.81	-0.6	-0.75	-0.23
Normalized Diluted EPS	-2.5	-1.81	-0.6	-0.75	-0.23
Supplemental Items
EBITDA	-4.68M	-7.44M	-6.23M	-3.77M	-1.21M
EBITA	-4.72M	-7.48M	-6.27M	-3.8M	-1.25M
EBIT	-4.72M	-7.48M	-6.27M	-3.8M	-1.25M
Effective Tax Rate - (Ratio)	-	-	-0.03	-5.3	128.51
Normalized Net Income	-6.22M	-6.26M	-2.3M	-2.97M	-998K
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	914K	2.5M	3.49M	10.91M	21.77M
General and Administrative Expenses	2.07M	3.71M	3.36M	3.08M	4.12M
Research And Development Expense From Footnotes	1.74M	1.4M	1.53M	1.8M	1.55M
Stock-Based Comp., R&D Exp. (Total)	64K	109K	120K	102K	250K
Stock-Based Comp., S&M Exp. (Total)	121K	490K	223K	96K	396K
Stock-Based Comp., G&A Exp. (Total)	343K	1.56M	624K	656K	1.41M
Stock-Based Comp., Other (Total)	-	-1K	-	-	-
Total Stock-Based Compensation	528K	2.16M	967K	854K	2.06M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.34M	11.05M	4.95M	3.88M	5.01M
Total Cash And Short Term Investments	2.34M	11.05M	4.95M	3.88M	5.01M
Accounts Receivable, Total	2K	-	62K	249K	250K
Other Receivables	1.13M	169K	181K	445K	286K
Total Receivables	1.13M	169K	243K	694K	536K
Inventory	430K	510K	1.13M	1.75M	3.32M
Prepaid Expenses	309K	715K	453K	340K	67K
Other Current Assets, Total	72K	79K	104K	138K	219K
Total Current Assets	4.28M	12.52M	6.88M	6.8M	9.15M
Net Property Plant And Equipment	56K	54K	98K	136K	113K
Total Assets	4.33M	12.58M	6.98M	6.94M	9.26M
Liabilities
Accounts Payable, Total	527K	53K	95K	112K	185K
Accrued Expenses, Total	384K	432K	318K	463K	478K
Current Portion of Leases	37K	1K	14K	22K	10K
Other Current Liabilities	6.99M	3.08M	304K	1.95M	1.56M
Total Current Liabilities	7.94M	3.56M	731K	2.54M	2.24M
Long-Term Leases	1K	-	20K	11K	-
Total Liabilities	7.94M	3.56M	751K	2.55M	2.24M
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	10.96M	33.66M	34.77M	37.18M	40.08M
Retained Earnings	-14.56M	-24.61M	-28.37M	-33.07M	-34.91M
Total Common Equity	-3.61M	9.06M	6.39M	4.1M	5.17M
Minority Interest	-	-44K	-169K	283K	1.86M
Total Equity	-3.61M	9.01M	6.22M	4.39M	7.02M
Total Liabilities And Equity	4.33M	12.58M	6.98M	6.94M	9.26M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.31M	3.82M	3.87M	4.32M	4.48M
ECS Total Common Shares Outstanding	2.9M	3.82M	3.84M	4.12M	4.46M
Book Value / Share	-1.24	2.37	1.66	1	1.16
Tangible Book Value	-3.61M	9.06M	6.39M	4.1M	5.17M
Tangible Book Value Per Share	-1.24	2.37	1.66	1	1.16
Total Debt	38K	1K	34K	33K	10K
Net Debt	-2.3M	-11.05M	-4.91M	-3.85M	-5M
Minority Interest, Total (Incl. Fin. Div)	-	-44K	-169K	283K	1.86M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	203K	188K	224K	214K	184K
Inventories - Finished Goods, Total	227K	322K	907K	1.53M	3.27M
Full Time Employees	-	-	-	-	-
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-9.95M	-10.05M	-3.76M	-4.7M	-1.83M
Depreciation & Amortization - CF	40K	43K	35K	33K	35K
Depreciation & Amortization, Total	40K	43K	35K	33K	35K
Stock-Based Compensation (CF)	527K	2.16M	967K	854K	2.01M
Other Operating Activities, Total	5.22M	2.18M	-2.77M	702K	-584K
Change In Accounts Receivable	-2K	2K	-15K	-2K	17K
Change In Inventories	-430K	-79K	-621K	-616K	-1.57M
Change In Accounts Payable	500K	-474K	42K	17K	72K
Change in Other Net Operating Assets	406K	-418K	63K	-192K	278K
Cash from Operations	-3.69M	-6.63M	-6.07M	-3.9M	-1.58M
Capital Expenditure	-	-41K	-26K	-46K	-15K
Other Investing Activities, Total	-	-7K	-5K	-38K	69K
Cash from Investing	-	-48K	-31K	-84K	54K
Long-Term Debt Repaid, Total	-39K	-38K	-11K	-22K	-22K
Total Debt Repaid	-39K	-38K	-11K	-22K	-22K
Issuance of Common Stock	4.06M	11.92M	136K	1.56M	891K
Other Financing Activities, Total	-	3.43M	-	1.38M	1.84M
Cash from Financing	4.02M	15.3M	125K	2.92M	2.7M
Foreign Exchange Rate Adjustments	28K	84K	-128K	9K	-56K
Net Change in Cash	365K	8.71M	-6.1M	-1.06M	1.12M
Supplemental Items
Levered Free Cash Flow	2.99M	-7.41M	-6.25M	-720K	-220K
Unlevered Free Cash Flow	2.99M	-7.4M	-6.24M	-720K	-215K
Change In Net Working Capital	-5.38M	4.89M	3.3M	-816K	1.51M
Net Debt Issued / Repaid	-39K	-38K	-11K	-22K	-22K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-85.4	-55.3	-40.06	-34.16	-9.62
Return on Total Capital	283.41	-171.78	-51.29	-44.52	-13.61
Return On Equity %	907.29	-373.46	-51.05	-80.07	-4.59
Return on Common Equity	907.29	-368.83	-48.73	-89.55	-39.57
Margin Analysis
Gross Profit Margin %	37.5	61.73	82.34	87.71	88.96
SG&A Margin	37.3K	3.16K	267.57	102.4	87.93
EBITDA Margin %	-58.56K	-3.79K	-243.49	-27.6	-4.12
EBITA Margin %	-59.06K	-3.82K	-244.86	-27.85	-4.24
EBIT Margin %	-59.06K	-3.82K	-244.86	-27.85	-4.24
Income From Continuing Operations Margin %	-124K	-5.15K	-151.97	-31.1	-0.89
Net Income Margin %	-124K	-5.13K	-147.09	-34.41	-6.23
Net Avail. For Common Margin %	-124K	-5.13K	-147.09	-34.41	-6.23
Normalized Net Income Margin	-77.76K	-3.2K	-90.07	-21.77	-3.39
Levered Free Cash Flow Margin	37.44K	-3.78K	-244.06	-5.27	-0.75
Unlevered Free Cash Flow Margin	37.44K	-3.78K	-244.01	-5.27	-0.73
Asset Turnover
Asset Turnover	0	0.02	0.26	1.96	3.63
Fixed Assets Turnover	0.11	3.56	33.67	116.73	236.44
Receivables Turnover (Average Receivables)	-	-	-	87.83	117.98
Inventory Turnover (Average Inventory)	-	0.16	0.55	1.17	1.28
Short Term Liquidity
Current Ratio	0.54	3.51	9.41	2.68	4.09
Quick Ratio	0.44	3.15	7.1	1.8	2.48
Operating Cash Flow to Current Liabilities	-0.46	-1.86	-8.3	-1.54	-0.71
Days Sales Outstanding (Average Receivables)	-	-	-	4.16	3.1
Days Outstanding Inventory (Average Inventory)	-	2.29K	662.57	312.83	285.14
Average Days Payable Outstanding	-	682.9	25.17	16.46	11.28
Cash Conversion Cycle (Average Days)	-	-	-	300.52	276.97
Long Term Solvency
Total Debt/Equity	-1.05	0.01	0.55	0.75	0.14
Total Debt / Total Capital	-1.06	0.01	0.54	0.75	0.14
LT Debt/Equity	-0.03	-	0.32	0.25	-
Long-Term Debt / Total Capital	-0.03	-	0.32	0.25	-
Total Liabilities / Total Assets	183.23	28.34	10.77	36.8	24.17
EBIT / Interest Expense	-	-575.38	-3.13K	-	-178.14
EBITDA / Interest Expense	-	-572.08	-3.12K	-	-173.14
(EBITDA - Capex) / Interest Expense	-	-575.23	-3.13K	-	-175.29
Total Debt / EBITDA	-0.01	-0	-0.01	-0.01	-0.01
Net Debt / EBITDA	0.49	1.49	0.79	1.02	4.12
Total Debt / (EBITDA - Capex)	-0.01	-0	-0.01	-0.01	-0.01
Net Debt / (EBITDA - Capex)	0.49	1.48	0.79	1.01	4.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	2.35K	1.21K	433.68	115.55
Gross Profit, 1 Yr. Growth %	-	3.93K	1.64K	468.49	118.63
EBITDA, 1 Yr. Growth %	57.32	58.74	-16.22	-39.5	-67.85
EBITA, 1 Yr. Growth %	57.45	58.31	-16.23	-39.31	-67.21
EBIT, 1 Yr. Growth %	57.45	58.31	-16.23	-39.31	-67.21
Earnings From Cont. Operations, 1 Yr. Growth %	198.44	1.39	-61.46	9.23	-93.83
Net Income, 1 Yr. Growth %	198.44	0.94	-62.54	24.87	-60.98
Normalized Net Income, 1 Yr. Growth %	198.44	0.68	-63.2	28.99	-66.45
Diluted EPS Before Extra, 1 Yr. Growth %	122.22	-27.16	-66.21	20.96	-64.19
Accounts Receivable, 1 Yr. Growth %	-	-	-	301.61	0.4
Inventory, 1 Yr. Growth %	-	18.6	121.76	54.46	89.87
Net Property, Plant and Equip., 1 Yr. Growth %	-41.05	-3.57	81.48	38.78	-16.91
Total Assets, 1 Yr. Growth %	67.85	190.15	-44.52	-0.52	33.43
Tangible Book Value, 1 Yr. Growth %	-355.27	-351.04	-29.39	-35.83	25.93
Common Equity, 1 Yr. Growth %	-355.27	-351.04	-29.39	-35.83	25.93
Cash From Operations, 1 Yr. Growth %	35.8	79.79	-8.48	-35.65	-59.55
Capital Expenditures, 1 Yr. Growth %	-	-	-36.59	76.92	-67.39
Levered Free Cash Flow, 1 Yr. Growth %	-409.51	-284.93	-15.68	-88.47	-69.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-417.72	-284.5	-15.61	-88.47	-70.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	1.69K	734.74	239.17
Gross Profit, 2 Yr. CAGR %	-	-	2.55K	894.95	252.54
EBITDA, 2 Yr. CAGR %	-	58.03	15.33	-28.8	-55.9
EBITA, 2 Yr. CAGR %	53.75	57.88	15.16	-28.7	-55.39
EBIT, 2 Yr. CAGR %	53.75	57.88	15.16	-28.7	-55.39
Earnings From Cont. Operations, 2 Yr. CAGR %	120.7	73.95	-37.49	-35.12	-74.04
Net Income, 2 Yr. CAGR %	120.7	73.57	-38.5	-31.6	-30.2
Normalized Net Income, 2 Yr. CAGR %	120.7	73.34	-39.13	-31.1	-34.21
Diluted EPS Before Extra, 2 Yr. CAGR %	59.34	27.23	-50.39	-36.07	-34.19
Accounts Receivable, 2 Yr. CAGR %	-	-	456.78	-	100.8
Inventory, 2 Yr. CAGR %	-	-	62.18	85.08	71.25
Net Property, Plant and Equip., 2 Yr. CAGR %	332.05	-24.61	32.29	58.7	7.38
Total Assets, 2 Yr. CAGR %	156.26	120.69	26.87	-25.71	15.21
Tangible Book Value, 2 Yr. CAGR %	432.93	153.15	33.14	-32.69	-10.11
Common Equity, 2 Yr. CAGR %	432.93	153.15	33.14	-32.69	-10.11
Cash From Operations, 2 Yr. CAGR %	53.82	56.26	28.28	-23.26	-48.98
Capital Expenditures, 2 Yr. CAGR %	-	113.44	-	5.92	-24.04
Levered Free Cash Flow, 2 Yr. CAGR %	-	176.69	24.86	-68.83	-81.24
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	180.19	24.77	-68.81	-81.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	1.1K	431.55
Gross Profit, 3 Yr. CAGR %	-	-	-	1.49K	500.39
EBITDA, 3 Yr. CAGR %	-	-	27.9	-6.99	-45.38
EBITA, 3 Yr. CAGR %	-	55.25	27.81	-6.98	-44.96
EBIT, 3 Yr. CAGR %	-	55.25	27.81	-6.98	-44.96
Earnings From Cont. Operations, 3 Yr. CAGR %	-	70.29	5.26	-24.71	-70.39
Net Income, 3 Yr. CAGR %	-	70.04	4.12	-22.13	-43.27
Normalized Net Income, 3 Yr. CAGR %	-	69.89	3.41	-21.81	-45.79
Diluted EPS Before Extra, 3 Yr. CAGR %	-	22.75	-18.22	-33.23	-47.3
Accounts Receivable, 3 Yr. CAGR %	-	-	-	399.33	-
Inventory, 3 Yr. CAGR %	-	-	-	59.57	86.66
Net Property, Plant and Equip., 3 Yr. CAGR %	-	162.07	1.04	34.42	27.91
Total Assets, 3 Yr. CAGR %	-	167.09	39.28	16.99	-9.7
Tangible Book Value, 3 Yr. CAGR %	-	314.66	65.4	4.39	-17.06
Common Equity, 3 Yr. CAGR %	-	314.66	65.4	4.39	-17.06
Cash From Operations, 3 Yr. CAGR %	-	62.03	30.74	1.92	-38.01
Capital Expenditures, 3 Yr. CAGR %	-	99.77	42.42	-	-28.48
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	86.19	-43.57	-69.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	87.81	-43.59	-69.24
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	-16.46
EBITA, 5 Yr. CAGR %	-	-	-	13.73	-16.11
EBIT, 5 Yr. CAGR %	-	-	-	13.73	-16.11
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	15.76	-39.88
Net Income, 5 Yr. CAGR %	-	-	-	18.13	-11.27
Normalized Net Income, 5 Yr. CAGR %	-	-	-	18.41	-13.7
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-5.44	-25.02
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	114.43	3.53
Total Assets, 5 Yr. CAGR %	-	-	-	60.09	29.1
Tangible Book Value, 5 Yr. CAGR %	-	-	-	100.38	29.6
Common Equity, 5 Yr. CAGR %	-	-	-	100.38	29.6
Cash From Operations, 5 Yr. CAGR %	-	-	-	20.16	-10.27
Capital Expenditures, 5 Yr. CAGR %	-	-	-	54.99	10.76
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-25.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-25.57